The following were more common in the lower glycemic criteria group
Use of health services
Use of pharmacologic agents
Maternal and infant health were generally similar between the two groups
There was no differences in adverse effects between the groups
Among the women in both groups who had glucose test results that fell between the lower and higher glycemic criteria
Those who were treated for GDM (195 women) benefitted and had fewer large for gestational age infants than those who were not treated (178 women)
Using lower GDM glycemic criteria (IADPSG) did not improve pregnancy outcomes or lower the risk of large for gestational age infants vs higher glycemic criteria (current Australia & New Zealand standard)
The authors state
Two previous randomized trials have compared the IADPSG criteria with the Carpenter–Coustan screening criteria, but data from trials comparing the IADPSG criteria with the criteria currently recommended for use in New Zealand are lacking
Both previous trials showed that there were more women who received a diagnosis of gestational diabetes with the IADPSG criteria than with the Carpenter–Coustan screening criteria but that there was no improvement in perinatal health
Overall, the risks of giving birth to a large-for-gestational-age infant and of other infant or maternal complications were not lower with the lower glycemic criteria than with the higher glycemic criteria
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan